Almirall SA's new CEO is seeking to reassure investors he steadied the ship in 2017 and has positioned it for future growth. Announcing a 16% drop in net sales to €639m last year, Peter Guenter emphasized ongoing cost savings, new control mechanisms and a focus on dermatology growth opportunities as his tools for getting Almirall on course for success. He promised a return to growth in revenues and earnings in 2018, but wouldn't offer any longer-term targets.
Among the challenges he has faced since assuming control at Almirall in October 2017 have been sorting out business irregularities...








